UroGen Pharma
URGN
URGN
81 hedge funds and large institutions have $261M invested in UroGen Pharma in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.34% less ownership
Funds ownership: 68.21% → 65.87% (-2.3%)
9% less capital invested
Capital invested by funds: $287M → $261M (-$25.7M)
59% less call options, than puts
Call options by funds: $2.05M | Put options by funds: $4.97M
Holders
81
Holding in Top 10
2
Calls
$2.05M
Puts
$4.97M
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.03M | |
| 3 | +$791K | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$713K |
| 5 |
Renaissance Technologies
New York
|
+$591K |
Top Sellers
| 1 | -$8.89M | |
| 2 | -$2.8M | |
| 3 | -$1.48M | |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$934K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$868K |